Location: Home
  • search
  • go
  • Relate News
  • 9/12/2020China Only 3% in World TCM Market
  • 9/12/2020China puts more stress on drug discoveries
  • 9/12/2020Pfizer expands strategic presence in China
  • 9/12/2020Review of Chinese Pharma Industry Trends in the 3rd Quarter, 2005
  • 9/12/2020Financing bio-pharmaceutical sector in China
  • 9/12/2020Six reasons for the widespread popularity of imported medical devices ...
  • 9/12/2020State Council report criticizes medical reform in China
  • 9/12/2020Chinese OTC market rises over 20% annually
  • 9/11/2020Recent Executive Moves
  • 9/11/2020China Issues the Guidance Policy for Strengthening and Enhancing BMI E...
  • 9/11/2020CDE Solicits Comments on the Draft Technical Guidelines for Drug Inter...
  • 9/11/2020Vice Premier Calls for Deepened Reform of Centralized Drug and Medical...
  • 9/10/2020CMAB and Laekna Enter Partnership for ICI Drug Candidate
  • 9/10/2020Zai Lab Announces Chinese Approval of ZEJULA for First-Line Maintenanc...
  • 9/10/2020US Senator Requests CFIUS Review of GNC Acquisition by Harbin Pharma
  • 9/10/2020China Approves Clinical Study of Its First Nasal Spray Covid-19 Vaccin...
  • 9/10/2020Junshi Receives FDA Breakthru Therapy Designation for Toripalimab for ...
  • 9/10/2020SinoPharm and Gilead Enter Strategic Deal for HBV Drug Vemlidy in Chin...
  • 9/10/2020CDE Solicits Comments on the Draft Technical Guidelines for Pharmaceut...
  • 9/10/2020New NHSA Guidance Document Calls for Drug Price Surveillance and Cost ...
  • 9/10/2020Exscientia and Huadong Medicine Team Up for AI-based Drug Discovery
  • 9/10/2020Gannex and Galmed Expand Development Programs For NASH
  • 9/9/2020CANbridge Granted Chinese Approval of Hunterase for Hunter Syndrome in...
  • 9/9/2020China Debates Cutting US Access to Drugs as Hostilities Spike
  • 9/9/2020SCMP: Chinese Biotech Remains Heated with Surging M&A and IPO Deal...
  • 9/9/2020Sinovac Reports Preliminary Phase I/II Results of COVID-19 Vaccine in ...
  • 9/9/2020CDE Issues the Technical Guidelines for Clinical Research of AMD Drugs
  • 9/9/2020CDE Issues the Guidelines on Clinical Pharmacology of Neutralizing Ant...
  • 9/8/2020China Considers to Regulate Online Healthcare Mutual Aid Platforms
  • 9/8/2020CStone's Priority Review NDA for Pralsetinib Accepted in China
  • Page:221/775 Total number of articles:23222: [First][<<] [219] [220] [221] [222] [223] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group